|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021747,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0205466,
umls-concept:C0332293,
umls-concept:C0663655,
umls-concept:C0871261,
umls-concept:C1521828,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-12-2
|
|
pubmed:abstractText |
The combination of pegylated interferon (PEG-IFN) plus ribavirin (RBV) is the standard of care for hepatitis C virus (HCV) treatment in HIV-coinfected individuals. In 2007, abacavir (ABC)-based antiretroviral therapy was, for the first time, reported to be associated with early virological failure during HCV treatment. The aim of our study was to evaluate the effect of ABC on the response rate to HCV therapy.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-10405412,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-12700452,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-15090831,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-15282351,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-15316335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-15598915,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-15865229,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-15918333,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-17502718,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-17938129,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-18240862,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-18257771,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-18572756,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-2435003,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19043930-9174176
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/abacavir,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
953-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19043930-Adult,
pubmed-meshheading:19043930-Anti-HIV Agents,
pubmed-meshheading:19043930-Antiviral Agents,
pubmed-meshheading:19043930-Dideoxynucleosides,
pubmed-meshheading:19043930-Drug Therapy, Combination,
pubmed-meshheading:19043930-Female,
pubmed-meshheading:19043930-HIV Infections,
pubmed-meshheading:19043930-HIV-1,
pubmed-meshheading:19043930-Hepacivirus,
pubmed-meshheading:19043930-Hepatitis C, Chronic,
pubmed-meshheading:19043930-Humans,
pubmed-meshheading:19043930-Interferon-alpha,
pubmed-meshheading:19043930-Male,
pubmed-meshheading:19043930-Polyethylene Glycols,
pubmed-meshheading:19043930-Recombinant Proteins,
pubmed-meshheading:19043930-Reverse Transcriptase Inhibitors,
pubmed-meshheading:19043930-Ribavirin,
pubmed-meshheading:19043930-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.
|
|
pubmed:affiliation |
Infectious Diseases Unit, Hospital Clinic, Barcelona, Spain. natalialaufer@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
